Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Beth Israel Deaconess Med. Ctr., ACTG CRS
mi
from
Boston, MA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Beth Israel Deaconess Med. Ctr., ACTG CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Henry Ford Hosp. CRS
mi
from
Detroit, MI
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Henry Ford Hosp. CRS
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Washington University Therapeutics (WT) CRS
mi
from
St. Louis, MO
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Washington University Therapeutics (WT) CRS
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Cooper Univ. Hosp. CRS
mi
from
Camden, NJ
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Cooper Univ. Hosp. CRS
mi
from
Camden, NJ
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
New Jersey Medical School- Adult Clinical Research Ctr. CRS
mi
from
Newark, NJ
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
New Jersey Medical School- Adult Clinical Research Ctr. CRS
mi
from
Newark, NJ
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Weill Cornell Chelsea CRS
mi
from
New York, NY
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Weill Cornell Chelsea CRS
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Columbia P&S CRS
mi
from
New York, NY
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Columbia P&S CRS
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Columbia IMPAACT CRS
mi
from
New York, NY
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Columbia IMPAACT CRS
mi
from
New York, NY
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Trillium Health ACTG CRS
mi
from
Rochester, NY
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Trillium Health ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Chapel Hill CRS
mi
from
Chapel Hill, NC
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Chapel Hill CRS
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Duke Univ. Med. Ctr. Adult CRS
mi
from
Durham, NC
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Duke Univ. Med. Ctr. Adult CRS
mi
from
Durham, NC
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Greensboro CRS
mi
from
Greensboro, NC
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Greensboro CRS
mi
from
Greensboro, NC
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Cincinnati CRS
mi
from
Cincinnati, OH
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Cincinnati CRS
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Case CRS
mi
from
Cleveland, OH
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Case CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
MetroHealth CRS
mi
from
Cleveland, OH
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
MetroHealth CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Ohio State University CRS
mi
from
Columbus, OH
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Ohio State University CRS
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
The Research & Education Group-Portland CRS
mi
from
Portland, OR
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
The Research & Education Group-Portland CRS
mi
from
Portland, OR
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Penn Therapeutics Crs
mi
from
Philadelphia, PA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Penn Therapeutics Crs
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Thomas Jefferson Univ. Med. Ctr. CRS
mi
from
Philadelphia, PA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Thomas Jefferson Univ. Med. Ctr. CRS
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
University of Pittsburgh CRS
mi
from
Pittsburgh, PA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
University of Pittsburgh CRS
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
The Miriam Hospital Clinical Research Site (TMH CRS) CRS
mi
from
Providence, RI
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
The Miriam Hospital Clinical Research Site (TMH CRS) CRS
mi
from
Providence, RI
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Vanderbilt Therapeutics (VT) CRS
mi
from
Nashville, TN
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Vanderbilt Therapeutics (VT) CRS
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Trinity Health and Wellness Center CRS
mi
from
Dallas, TX
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Trinity Health and Wellness Center CRS
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Texas Children's Hosp. CRS
mi
from
Houston, TX
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Texas Children's Hosp. CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Houston AIDS Research Team CRS
mi
from
Houston, TX
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Houston AIDS Research Team CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Virginia Commonwealth Univ. Medical Ctr. CRS
mi
from
Richmond, VA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Virginia Commonwealth Univ. Medical Ctr. CRS
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
University of Washington AIDS CRS
mi
from
Seattle, WA
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
University of Washington AIDS CRS
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated:  8/11/2015
Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS
mi
from
Rio de Janeiro,
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females
Status: Enrolling
Updated: 8/11/2015
Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS
mi
from
Rio de Janeiro,
Click here to add this to my saved trials
The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)
A Study to Evaluate the Influence of Metal Cation-Containing Antacids on MK-0518 Pharmacokinetics in HIV-Infected Subjects on a Stable Raltegravir-Containing Regimen
Status: Enrolling
Updated:  8/17/2015
Clinical Research Facility
mi
from
Miami, FL
The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)
A Study to Evaluate the Influence of Metal Cation-Containing Antacids on MK-0518 Pharmacokinetics in HIV-Infected Subjects on a Stable Raltegravir-Containing Regimen
Status: Enrolling
Updated: 8/17/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated:  8/18/2015
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated: 8/18/2015
UCLA, Center for Clinical AIDS Research and Education
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated:  8/18/2015
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated: 8/18/2015
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated:  8/18/2015
Siteman Cancer Center at Washington University
mi
from
Saint Louis, MO
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated: 8/18/2015
Siteman Cancer Center at Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated:  8/18/2015
Albert Einstein College of Medicine
mi
from
Bronx, NY
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated: 8/18/2015
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated:  8/18/2015
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated: 8/18/2015
Montefiore Medical Center - Moses Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated:  8/18/2015
Montefiore Medical Center-Einstein Campus
mi
from
Bronx, NY
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated: 8/18/2015
Montefiore Medical Center-Einstein Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated:  8/18/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
Phase I and Pharmacokinetic Study of Ibrutinib in HIV-Infected Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Multiple Myeloma
Status: Enrolling
Updated: 8/18/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients
Impact of Patient Navigators on Health Education and Quality of Life in Formerly Incarcerated Patients
Status: Enrolling
Updated:  8/18/2015
Hunter College of the City University of New York
mi
from
New York, NY
Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients
Impact of Patient Navigators on Health Education and Quality of Life in Formerly Incarcerated Patients
Status: Enrolling
Updated: 8/18/2015
Hunter College of the City University of New York
mi
from
New York, NY
Click here to add this to my saved trials
Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients
Impact of Patient Navigators on Health Education and Quality of Life in Formerly Incarcerated Patients
Status: Enrolling
Updated:  8/18/2015
Mount Sinai St. Luke's
mi
from
New York, NY
Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients
Impact of Patient Navigators on Health Education and Quality of Life in Formerly Incarcerated Patients
Status: Enrolling
Updated: 8/18/2015
Mount Sinai St. Luke's
mi
from
New York, NY
Click here to add this to my saved trials
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
Status: Enrolling
Updated:  8/19/2015
Los Angeles County Hospital University of Southern California (LAC USC)
mi
from
Los Angeles, CA
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
Status: Enrolling
Updated: 8/19/2015
Los Angeles County Hospital University of Southern California (LAC USC)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
Status: Enrolling
Updated:  8/19/2015
Los Angeles County University of Southern California
mi
from
Los Angeles, CA
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception
Status: Enrolling
Updated: 8/19/2015
Los Angeles County University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults
A Phase I Study of the Safety and Immunogenicity of PENNVAX-G DNA (ENV & GAG) Administered by Intramuscular Biojector 2000 or CELLECTRA Intramuscular Electroporation Device Followed by MVA-CMDR (HIV-1 CM235 ENV/CM240 GAG/POL) Boost in Healthy, HIV Uninfected Adults
Status: Enrolling
Updated:  8/27/2015
Rockville Vaccine Assessment Clinic (RVAC)
mi
from
Rockville, MD
Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults
A Phase I Study of the Safety and Immunogenicity of PENNVAX-G DNA (ENV & GAG) Administered by Intramuscular Biojector 2000 or CELLECTRA Intramuscular Electroporation Device Followed by MVA-CMDR (HIV-1 CM235 ENV/CM240 GAG/POL) Boost in Healthy, HIV Uninfected Adults
Status: Enrolling
Updated: 8/27/2015
Rockville Vaccine Assessment Clinic (RVAC)
mi
from
Rockville, MD
Click here to add this to my saved trials
Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults
A Phase I Study of the Safety and Immunogenicity of PENNVAX-G DNA (ENV & GAG) Administered by Intramuscular Biojector 2000 or CELLECTRA Intramuscular Electroporation Device Followed by MVA-CMDR (HIV-1 CM235 ENV/CM240 GAG/POL) Boost in Healthy, HIV Uninfected Adults
Status: Enrolling
Updated:  8/27/2015
Kenya Med. Research Inst./Walter Reed Project, Clinical Research Centre, Off Hospital Road. Kericho
mi
from
Kericho,
Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults
A Phase I Study of the Safety and Immunogenicity of PENNVAX-G DNA (ENV & GAG) Administered by Intramuscular Biojector 2000 or CELLECTRA Intramuscular Electroporation Device Followed by MVA-CMDR (HIV-1 CM235 ENV/CM240 GAG/POL) Boost in Healthy, HIV Uninfected Adults
Status: Enrolling
Updated: 8/27/2015
Kenya Med. Research Inst./Walter Reed Project, Clinical Research Centre, Off Hospital Road. Kericho
mi
from
Kericho,
Click here to add this to my saved trials
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Exploring the Role of Gut-associated TH17 in Microbial Translocation in HIV and HCV/HIV Co-infected Patients
Status: Enrolling
Updated:  8/27/2015
University of Cincinnati
mi
from
Cincinnati, OH
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Exploring the Role of Gut-associated TH17 in Microbial Translocation in HIV and HCV/HIV Co-infected Patients
Status: Enrolling
Updated: 8/27/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
Status: Enrolling
Updated:  8/27/2015
St. Luke's Roosevelt Hospital
mi
from
New York, NY
HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
Status: Enrolling
Updated: 8/27/2015
St. Luke's Roosevelt Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
A Two-site, Phase 1, Partially-blinded, Placebo-controlled Safety, Acceptability and Pharmacokinetic Trial of Topical, Vaginally-formulated Tenofovir 1% Gel Applied Rectally Compared With Oral 300 mg Tenofovir Disoproxil Fumarate in HIV-1 Seronegative Adults
Status: Enrolling
Updated:  8/27/2015
UCLA Center for HIV Prevention Research
mi
from
Los Angeles, CA
Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
A Two-site, Phase 1, Partially-blinded, Placebo-controlled Safety, Acceptability and Pharmacokinetic Trial of Topical, Vaginally-formulated Tenofovir 1% Gel Applied Rectally Compared With Oral 300 mg Tenofovir Disoproxil Fumarate in HIV-1 Seronegative Adults
Status: Enrolling
Updated: 8/27/2015
UCLA Center for HIV Prevention Research
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
A Two-site, Phase 1, Partially-blinded, Placebo-controlled Safety, Acceptability and Pharmacokinetic Trial of Topical, Vaginally-formulated Tenofovir 1% Gel Applied Rectally Compared With Oral 300 mg Tenofovir Disoproxil Fumarate in HIV-1 Seronegative Adults
Status: Enrolling
Updated:  8/27/2015
University of Pittsburgh Clinical Research Unit
mi
from
Pittsburgh, PA
Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
A Two-site, Phase 1, Partially-blinded, Placebo-controlled Safety, Acceptability and Pharmacokinetic Trial of Topical, Vaginally-formulated Tenofovir 1% Gel Applied Rectally Compared With Oral 300 mg Tenofovir Disoproxil Fumarate in HIV-1 Seronegative Adults
Status: Enrolling
Updated: 8/27/2015
University of Pittsburgh Clinical Research Unit
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination With Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil
Status: Enrolling
Updated:  8/28/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination With Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil
Status: Enrolling
Updated: 8/28/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy Subjects
A Study to Determine the Concentration-Electrocardiographic Effects of Efavirenz in Healthy Subjects Enriched for CYP2B6 Polymorphisms
Status: Enrolling
Updated:  9/3/2015
Parexel International - Baltimore Epcu
mi
from
Baltimore, MD
Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy Subjects
A Study to Determine the Concentration-Electrocardiographic Effects of Efavirenz in Healthy Subjects Enriched for CYP2B6 Polymorphisms
Status: Enrolling
Updated: 9/3/2015
Parexel International - Baltimore Epcu
mi
from
Baltimore, MD
Click here to add this to my saved trials